Published Date: November, 2017
The report on global vaccine market is an in depth analysis of the segments and sub-segments in the vaccine market. The report provides analysis for the global as well as regional markets over the period of 2015 to 2023. According to report the global vaccine market is expected to grow at a CAGR of 11% over the forecast period of 2017 - 2023.
Figure 1: Global Vaccine Market by value 2015 - 2023
The report on global vaccine market covers segments such as type and application. The type segments include conjugate, recombinant, inactivated, combination, attenuated and others. On the basis of application, the global vaccine market is categorized into infectious disease, cancer, allergy, and others.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015 – 2023.
Figure 2: Global Vaccine Market by Region, CAGR %, 2015 - 2023
The countries covered in the North America region include the U.S., Canada and Mexico; while Asia-Pacific includes China, Japan, India, South Korea and Malaysia among others. Moreover, The European region covers countries such as, Germany, UK, France, Spain and Rest of Europe. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2017 - 2023.
The report provides profiles of the companies in the global vaccine market such as, Mitsubishi Tanabe, AstraZeneca, Merck & Co. Inc, GlaxoSmithKline plc (GSK), Pfizer Inc., SANOFI S.A, NOVARTIS AG, Takeda Pharmaceuticals, Astellas Pharma Inc. and Emergent BioSolutions.
The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the Global Vaccine Market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider.
The report provides insights into the market using analytical tools such as Porter’s five forces analysis and DRO analysis of vaccine market. Moreover, the study highlights current market trends and provides forecast from 2017 to 2023. We also have highlighted future trends in the Vaccine Market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market.
This report will help manufacturers, suppliers and distributors of the vaccine market to understand the present and future trends in this market and formulate their strategies accordingly.
1.1 Report Description
1.2 Research Methods
1.3 Research Approaches
2. Executive Summary
3. Global Vaccine Market Overview
3.2 Market Dynamics
3.3 Porter’s Five Forces Analysis
3.4 IGR – Growth Matrix Analysis
3.5 Competitive Landscape in the Global Vaccine Market
4. Global Vaccine Market by Type 2017 - 2023
5. Global Vaccine Market by Application 2017 - 2023
5.1 Infectious Disease
6. Global Vaccine Market by Regions 2017 - 2023
6.1 North America
6.1.1 North America Vaccine Market by Type
6.1.2 North America Vaccine Market by Application
6.1.3 North America Vaccine Market by Country
6.2.1 Europe Vaccine Market by Type
6.2.2 Europe Vaccine Market by Application
6.2.3 Europe Vaccine Market by Country
6.3.1 Asia-Pacific Vaccine Market by Type
6.3.2 Asia-Pacific Vaccine Market by Application
6.3.3 Asia-Pacific Vaccine Market by Country
6.4.1 RoW Vaccine Market by Type
6.4.2 RoW Vaccine Market by Application
6.4.3 RoW Vaccine Market by Sub-region
7. Companies Covered
7.1 Mitsubishi Tanabe
7.3 Merck & Co. Inc
7.4 GlaxoSmithKline plc (GSK)
7.5 Pfizer Inc.
7.6 SANOFI S.A
7.7 NOVARTIS AG
7.8 Takeda Pharmaceuticals
7.9 Astellas Pharma Inc.
7.10 Emergent BioSolutions